Intermittent Fasting (Alternate Day Fasting) in Healthy, Non-obese Adults: Protocol for a Cohort Trial with an Embedded Randomized Controlled Pilot Trial

Norbert J Tripolt, Slaven Stekovic, Felix Aberer, Jasmin Url, Peter N Pferschy, Sabrina Schröder, Nicolas Verheyen, Albrecht Schmidt, Ewald Kolesnik, Sophie H Narath, Regina Riedl, Barbara Obermayer-Pietsch, Thomas R Pieber, Frank Madeo, Harald Sourij, Norbert J Tripolt, Slaven Stekovic, Felix Aberer, Jasmin Url, Peter N Pferschy, Sabrina Schröder, Nicolas Verheyen, Albrecht Schmidt, Ewald Kolesnik, Sophie H Narath, Regina Riedl, Barbara Obermayer-Pietsch, Thomas R Pieber, Frank Madeo, Harald Sourij

Abstract

Background/objectives: Alternate day fasting (ADF) is a subtype of intermittent fasting and is defined as a continuous sequence of a fast day (100% energy restriction, zero calories) and a feed day (ad libitum food consumption), resulting in roughly 36-h fasting periods. Previous studies demonstrated weight reductions and improvements of cardiovascular risk factors with ADF in obese subjects. However, rigorous data on potential endocrine, metabolic and cardiovascular effects, besides weight loss, are lacking. Therefore we aim to investigate the short- and mid- to long-term clinical and molecular effects of ADF in healthy non-obese subjects.

Methods: We will perform a prospective cohort study with an embedded randomized controlled trial (RCT) including 90 healthy subjects. Thirty of them will have performed ADF for at least 6 months (mid-term group). Sixty healthy subjects without a particular diet before enrolment will serve as the control group. These subjects will be 1:1 randomized to either continuing their current diet or performing ADF for 4 weeks. All subjects will undergo study procedures that will be repeated in RCT participants after 4 weeks. These procedures will include assessment of outcome parameters, dual-energy X-ray absorptiometry, measurement of endothelial function, an oral glucose tolerance test, 24-h blood pressure measurement, retinal vessel analysis, echocardiography and physical activity measurement by an accelerometer. Blood, sputum, buccal mucosa and faeces will be collected for laboratory analyses. Participants in the RCT will wear a continuous glucose monitor to verify adherence to the study intervention.

Planned outcomes: The aim of this project is to investigate the effects of ADF on human physiology and molecular cellular processes. This investigation should gain in-depth mechanistic insights into the concept of ADF and form the basis for larger subsequent cohort recruitment and consecutive intervention studies.

Trial registration: NCT02673515; registered 24 November 2015. Current protocol date/version: 7 February 2017/version 1.8.

Keywords: Alternate day fasting; Blood pressure; Cell death; Cell signalling; Cohort study; Endothelial function; Glucose metabolism; Healthy subjects; Insulin sensitivity; Intermittent fasting.

Figures

Fig. 1
Fig. 1
Study design
Fig. 2
Fig. 2
Flow chart enrolment

References

    1. Faris MA, Kacimi S, Al-Kurd RA, Fararjeh MA, Bustanji YK, Mohammad MK, et al. Intermittent fasting during Ramadan attenuates proinflammatory cytokines and immune cells in healthy subjects. Nutr Res. 2012;32(12):947–955. doi: 10.1016/j.nutres.2012.06.021.
    1. Joslin PM, Bell RK, Swoap SJ. Obese mice on a high-fat alternate-day fasting regimen lose weight and improve glucose tolerance. J Anim Physiol Anim Nutr (Berl) 2017;101(5):1036–1045. doi: 10.1111/jpn.12546.
    1. Catenacci VA, Pan Z, Ostendorf D, Brannon S, Gozansky WS, Mattson MP, et al. A randomized pilot study comparing zero-calorie alternate-day fasting to daily caloric restriction in adults with obesity. Obesity (Silver Spring) 2016;24(9):1874–1883. doi: 10.1002/oby.21581.
    1. Varady KA, Bhutani S, Klempel MC, Kroeger CM, Trepanowski JF, Haus JM, et al. Alternate day fasting for weight loss in normal weight and overweight subjects: a randomized controlled trial. Nutr J. 2013;12(1):146. doi: 10.1186/1475-2891-12-146.
    1. Varady KA, Hoddy KK, Kroeger CM, Trepanowski JF, Klempel MC, Barnosky A, et al. Determinants of weight loss success with alternate day fasting. Obes Res Clin Pract. 2016;10(4):476–480. doi: 10.1016/j.orcp.2015.08.020.
    1. Pedersen CR, Hagemann I, Bock T, Buschard K. Intermittent feeding and fasting reduces diabetes incidence in BB rats. Autoimmunity. 1999;30(4):243–250. doi: 10.3109/08916939908993805.
    1. Anson RM, Guo Z, de Cabo R, Iyun T, Rios M, Hagepanos A, et al. Intermittent fasting dissociates beneficial effects of dietary restriction on glucose metabolism and neuronal resistance to injury from calorie intake. Proc Natl Acad Sci USA. 2003;100(10):6216–6220. doi: 10.1073/pnas.1035720100.
    1. Wan R, Camandola S, Mattson MP. Intermittent fasting and dietary supplementation with 2-deoxy-d-glucose improve functional and metabolic cardiovascular risk factors in rats. FASEB J. 2003;17(9):1133–1134. doi: 10.1096/fj.02-0996fje.
    1. Mager DE, Wan R, Brown M, Cheng A, Wareski P, Abernethy DR, et al. Caloric restriction and intermittent fasting alter spectral measures of heart rate and blood pressure variability in rats. FASEB J. 2006;20(6):631–637. doi: 10.1096/fj.05-5263com.
    1. Krizova E, Simek V. Influence of intermittent fasting and high-fat diet on morphological changes of the digestive system and on changes of lipid metabolism in the laboratory mouse. Physiol Res Acad Sci Bohemosl. 1996;45(2):145–151.
    1. Hatori M, Vollmers C, Zarrinpar A, DiTacchio L, Bushong EA, Gill S, et al. Time-restricted feeding without reducing caloric intake prevents metabolic diseases in mice fed a high-fat diet. Cell Metab. 2012;15(6):848–860. doi: 10.1016/j.cmet.2012.04.019.
    1. Duan W, Lee J, Guo Z, Mattson MP. Dietary restriction stimulates BDNF production in the brain and thereby protects neurons against excitotoxic injury. J Mol Neurosci MN. 2001;16(1):1–12. doi: 10.1385/JMN:16:1:1.
    1. Duan W, Mattson MP. Dietary restriction and 2-deoxyglucose administration improve behavioral outcome and reduce degeneration of dopaminergic neurons in models of Parkinson’s disease. J Neurosci Res. 1999;57(2):195–206. doi: 10.1002/(SICI)1097-4547(19990715)57:2<195::AID-JNR5>;2-P.
    1. Yu ZF, Mattson MP. Dietary restriction and 2-deoxyglucose administration reduce focal ischemic brain damage and improve behavioral outcome: evidence for a preconditioning mechanism. J Neurosci Res. 1999;57(6):830–839. doi: 10.1002/(SICI)1097-4547(19990915)57:6<830::AID-JNR8>;2-2.
    1. Carlson AJ, Hoelzel F. Apparent prolongation of the life span of rats by intermittent fasting. J Nutr. 1946;31:363–375. doi: 10.1093/jn/31.3.363.
    1. Goodrick CL, Ingram DK, Reynolds MA, Freeman JR, Cider N. Effects of intermittent feeding upon body weight and lifespan in inbred mice: interaction of genotype and age. Mech Ageing Dev. 1990;55(1):69–87. doi: 10.1016/0047-6374(90)90107-Q.
    1. Johnson JB, Laub DR, John S. The effect on health of alternate day calorie restriction: eating less and more than needed on alternate days prolongs life. Med Hypotheses. 2006;67(2):209–211. doi: 10.1016/j.mehy.2006.01.030.
    1. Varady KA, Dam VT, Klempel MC, Horne M, Cruz R, Kroeger CM, et al. Effects of weight loss via high fat vs. low fat alternate day fasting diets on free fatty acid profiles. Sci Rep. 2015;5:7561. doi: 10.1038/srep07561.
    1. Teng NI, Shahar S, Manaf ZA, Das SK, Taha CS, Ngah WZ. Efficacy of fasting calorie restriction on quality of life among aging men. Physiol Behav. 2011;104(5):1059–1064. doi: 10.1016/j.physbeh.2011.07.007.
    1. Klempel MC, Kroeger CM, Varady KA. Alternate day fasting (ADF) with a high-fat diet produces similar weight loss and cardio-protection as ADF with a low-fat diet. Metab Clin Exp. 2013;62(1):137–143. doi: 10.1016/j.metabol.2012.07.002.
    1. Bhutani S, Klempel MC, Kroeger CM, Trepanowski JF, Varady KA. Alternate day fasting and endurance exercise combine to reduce body weight and favorably alter plasma lipids in obese humans. Obesity. 2013;21(7):1370–1379. doi: 10.1002/oby.20353.
    1. Belza A, Toubro S, Stender S, Astrup A. Effect of diet-induced energy deficit and body fat reduction on high-sensitive CRP and other inflammatory markers in obese subjects. Int J Obes. 2009;33(4):456–464. doi: 10.1038/ijo.2009.27.
    1. Eshghinia S, Mohammadzadeh F. The effects of modified alternate-day fasting diet on weight loss and CAD risk factors in overweight and obese women. J Diabet Metab Disord. 2013;12(1):4. doi: 10.1186/2251-6581-12-4.
    1. Kroeger CM, Klempel MC, Bhutani S, Trepanowski JF, Tangney CC, Varady KA. Improvement in coronary heart disease risk factors during an intermittent fasting/calorie restriction regimen: relationship to adipokine modulations. Nutr Metab. 2012;9(1):98. doi: 10.1186/1743-7075-9-98.
    1. Heilbronn LK, Smith SR, Martin CK, Anton SD, Ravussin E. Alternate-day fasting in nonobese subjects: effects on body weight, body composition, and energy metabolism. Am J Clin Nutr. 2005;81(1):69–73. doi: 10.1093/ajcn/81.1.69.
    1. Harvie MN, Pegington M, Mattson MP, Frystyk J, Dillon B, Evans G, et al. The effects of intermittent or continuous energy restriction on weight loss and metabolic disease risk markers: a randomized trial in young overweight women. Int J Obes. 2011;35(5):714–727. doi: 10.1038/ijo.2010.171.
    1. Harvie M, Wright C, Pegington M, McMullan D, Mitchell E, Martin B, et al. The effect of intermittent energy and carbohydrate restriction v. daily energy restriction on weight loss and metabolic disease risk markers in overweight women. Br J Nutr. 2013;110(8):1534–1547. doi: 10.1017/S0007114513000792.
    1. Johnson JB, Summer W, Cutler RG, Martin B, Hyun DH, Dixit VD, et al. Alternate day calorie restriction improves clinical findings and reduces markers of oxidative stress and inflammation in overweight adults with moderate asthma. Free Radic Biol Med. 2007;42(5):665–674. doi: 10.1016/j.freeradbiomed.2006.12.005.
    1. Lang RM, Bierig M, Devereux RB, Flachskampf FA, Foster E, Pellikka PA, et al. Recommendations for chamber quantification. Eur J Echocardiogr. 2006;7(2):79–108. doi: 10.1016/j.euje.2005.12.014.
    1. Varady KA, Bhutani S, Church EC, Klempel MC. Short-term modified alternate-day fasting: a novel dietary strategy for weight loss and cardioprotection in obese adults. Am J Clin Nutr. 2009;90(5):1138–1143. doi: 10.3945/ajcn.2009.28380.
    1. Horne BD, Muhlestein JB, Lappe DL, May HT, Carlquist JF, Galenko O, et al. Randomized cross-over trial of short-term water-only fasting: metabolic and cardiovascular consequences. Nutr Metab Cardiovasc Dis. 2013;23(11):1050–1057. doi: 10.1016/j.numecd.2012.09.007.
    1. Klempel MC, Kroeger CM, Varady KA. Alternate day fasting increases LDL particle size independently of dietary fat content in obese humans. Eur J Clin Nutr. 2013;67(7):783–785. doi: 10.1038/ejcn.2013.83.
    1. Varady KA, Bhutani S, Klempel MC, Lamarche B. Improvements in LDL particle size and distribution by short-term alternate day modified fasting in obese adults. Br J Nutr. 2011;105(4):580–583. doi: 10.1017/S0007114510003788.
    1. Halberg N, Henriksen M, Soderhamn N, Stallknecht B, Ploug T, Schjerling P, et al. Effect of intermittent fasting and refeeding on insulin action in healthy men. J Appl Physiol (1985) 2005;99(6):2128–2136. doi: 10.1152/japplphysiol.00683.2005.
    1. Seimon RV, Roekenes JA, Zibellini J, Zhu B, Gibson AA, Hills AP, et al. Do intermittent diets provide physiological benefits over continuous diets for weight loss? A systematic review of clinical trials. Amsterdam: Molecular and Cellular Endocrinology; 2015.
    1. Matsuda M, DeFronzo RA. Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp. Diabetes Care. 1999;22(9):1462–1470. doi: 10.2337/diacare.22.9.1462.
    1. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985;28(7):412–419. doi: 10.1007/BF00280883.
    1. Katz A, Nambi SS, Mather K, Baron AD, Follmann DA, Sullivan G, et al. Quantitative insulin sensitivity check index: a simple, accurate method for assessing insulin sensitivity in humans. J Clin Endocrinol Metab. 2000;85(7):2402–2410. doi: 10.1210/jcem.85.7.6661.
    1. Stumvoll M, Van Haeften T, Fritsche A, Gerich J. Oral glucose tolerance test indexes for insulin sensitivity and secretion based on various availabilities of sampling times. Diabetes Care. 2001;24(4):796–797. doi: 10.2337/diacare.24.4.796.
    1. Bonetti PO, Pumper GM, Higano ST, Holmes DR, Jr, Kuvin JT, Lerman A. Noninvasive identification of patients with early coronary atherosclerosis by assessment of digital reactive hyperemia. J Am Coll Cardiol. 2004;44(11):2137–2141. doi: 10.1016/j.jacc.2004.08.062.
    1. Korhonen P, Syvanen K, Aarnio P. Surrogates of large artery versus small artery stiffness and ankle-brachial index. Int J Angiol. 2011;20(3):167–172. doi: 10.1055/s-0031-1284200.
    1. Bonetti PO, Lerman LO, Lerman A. Endothelial dysfunction: a marker of atherosclerotic risk. Arterioscler Thromb Vasc Biol. 2003;23(2):168–175. doi: 10.1161/01.ATV.0000051384.43104.FC.
    1. Jatoba LC, Grossmann U, Kunze C, Ottenbacher J, Stork W. Context-aware mobile health monitoring: evaluation of different pattern recognition methods for classification of physical activity. In: Conference proceedings: annual international conference of the IEEE engineering in medicine and biology society IEEE engineering in medicine and biology society conference, 2008;2008:5250–3
    1. Ernst ME, Bergus GR. Noninvasive 24-hour ambulatory blood pressure monitoring: overview of technology and clinical applications. Pharmacotherapy. 2002;22(5):597–612. doi: 10.1592/phco.22.8.597.33212.
    1. Weir JB. New methods for calculating metabolic rate with special reference to protein metabolism. J Physiol. 1949;109(1–2):1–9. doi: 10.1113/jphysiol.1949.sp004363.
    1. Mathiowetz V, Weber K, Volland G, Kashman N. Reliability and validity of grip and pinch strength evaluations. J Hand Surg. 1984;9(2):222–226. doi: 10.1016/S0363-5023(84)80146-X.
    1. White C, Dixon K, Samuel D, Stokes M. Handgrip and quadriceps muscle endurance testing in young adults. Springerplus. 2013;2:451. doi: 10.1186/2193-1801-2-451.
    1. Meneguetti DU, da Silva AF, Bosso R, Zan R, Ramos L. New method for detection of mutagenicity in oral mucosa the through of micronucleus test. HOAJ Biol. 2012;1:8. doi: 10.7243/2050-0874-1-8.
    1. Holland N, Bolognesi C, Kirsch-Volders M, Bonassi S, Zeiger E, Knasmueller S, et al. The micronucleus assay in human buccal cells as a tool for biomonitoring DNA damage: the HUMN project perspective on current status and knowledge gaps. Mutat Res. 2008;659(1–2):93–108. doi: 10.1016/j.mrrev.2008.03.007.
    1. Thomas P, Holland N, Bolognesi C, Kirsch-Volders M, Bonassi S, Zeiger E, et al. Buccal micronucleus cytome assay. Nat Protoc. 2009;4(6):825–837. doi: 10.1038/nprot.2009.53.
    1. Nagueh SF, Smiseth OA, Appleton CP, Byrd BF, 3rd, Dokainish H, Edvardsen T, et al. Recommendations for the evaluation of left ventricular diastolic function by echocardiography: an update from the american society of echocardiography and the European Association of Cardiovascular Imaging. Eur Heart J Cardiovasc Imaging. 2016;17(12):1321–1360. doi: 10.1093/ehjci/jew082.
    1. Ainsworth BE, Bassett DR, Jr, Strath SJ, Swartz AM, O’Brien WL, Thompson RW, et al. Comparison of three methods for measuring the time spent in physical activity. Med Sci Sports Exerc. 2000;32(9 Suppl):S457–S464. doi: 10.1097/00005768-200009001-00004.
    1. Craig CL, Marshall AL, Sjostrom M, Bauman AE, Booth ML, Ainsworth BE, et al. International physical activity questionnaire: 12-country reliability and validity. Med Sci Sports Exerc. 2003;35(8):1381–1395. doi: 10.1249/01.MSS.0000078924.61453.FB.
    1. Ruta DA, Hurst NP, Kind P, Hunter M, Stubbings A. Measuring health status in British patients with rheumatoid arthritis: reliability, validity and responsiveness of the short form 36-item health survey (SF-36) Br J Rheumatol. 1998;37(4):425–436. doi: 10.1093/rheumatology/37.4.425.
    1. Ruta D, Garratt A, Abdalla M, Buckingham K, Russell I. The SF 36 health survey questionnaire. A valid measure of health status. BMJ. 1993;307(6901):448–449. doi: 10.1136/bmj.307.6901.448-b.
    1. Robert-Koch-Institut . DEGS - Studie zur Gesundheit Erwachsener in Deutschland. Berlin: Robert Koch Institut; 2009.
    1. Haftenberger M, Heuer T, Heidemann C, Kube F, Krems C, Mensink GB. Relative validation of a food frequency questionnaire for national health and nutrition monitoring. Nutr J. 2010;9:36. doi: 10.1186/1475-2891-9-36.
    1. R Foundation for Statistical Computing . R: a language and environment for statistical computing. Vienna: R Foundation for Statistical Computing; 2015.

Source: PubMed

Szponzorok és közreműködők

Egészségi állapot

Kábítószer-beavatkozások

3
Iratkozz fel